Results 81 to 90 of about 2,304,545 (309)

Quantitative data collection and study validity

open access: yes, 2013
The quality of data collection methods selected and the integrity of the data collected are integral to the; quantitative success of a study. This chapter focuses on data collection and study validity. After reading the chapter, readers should be able to
Osborne, Sonya, Schneider, Zevia
core  

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

Validity and Validation

open access: yes
Abstract Validity underscores all aspects of testing, from conceptualizing the targeted construct to evaluating the consequences of test score interpretations and uses. Validation entails constructing and evaluating coherent arguments for and against test score interpretations and uses, as well as the resulting consequences.
Lane Suzanne, Marion Scott F.
openaire   +1 more source

A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

open access: yesMolecular Oncology, EarlyView.
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both   +7 more
wiley   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Acute stress and fear scales during the COVID-19 pandemic: development and evaluation in a Costa Rican sample

open access: yesPoblación y Salud en Mesoamérica
Objective: In the context of the pandemic due to SARS-CoV-2, concerns were raised about how to adequately assess its impact on the wellbeing of the population.
Ana María Jurado-Solórzano   +6 more
doaj   +1 more source

Validation of functional assessment of chronic illness therapy - spiritual well-being scale (FACIT-Sp-12) in Serbian oncology patients [PDF]

open access: yesPsihologija
The Functional Assessment of Chronic Illness Therapy – Spiritual Well-Being scale (FACIT-Sp-12) is a 12-item questionnaire designed to assess spiritual well-being in individuals diagnosed with cancer and other chronic illnesses.
Klikovac Tamara   +2 more
doaj   +1 more source

An exploration into response validity [PDF]

open access: yes, 2018
Objectives: Performance validity tests (PVTs) and symptom validity tests (SVTs) have been recommended by the British Psychological Society to assist clinicians in validating assessment data. The current study aimed to explore the base rate of PVT failure
Hooker, J.
core  

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy